Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cerebellum (London, England)|November 10, 2021
Resting-State Low-Frequency Cerebellar Oscillations Can Be Abnormal in Parkinson's DiseaseTaylor J Bosch, Christopher Groth, Arun Singh
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2020
Depletion and Maturation of Myeloid-Derived Suppressor Cells in Murine Cancer ModelsChristopher Groth, Rebekka Weber, Jochen Utikal, et al.
Frontiers in Neurology|December 6, 2021
Safety and Clinical Effects of Switching From Intravenous to Oral Nimodipine Administration in Aneurysmal Subarachnoid HemorrhageJennifer Göttsche, Nils Schweingruber, Julian Christopher Groth, et al.
International Journal of Molecular Sciences|April 3, 2020
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in MelanomaVera Petrova, Ihor Arkhypov, Rebekka Weber, et al.
Cerebellum (London, England)|February 1, 2025
Cerebellar Oscillatory Patterns in Essential Tremor: Modulatory Effects of VIM-DBSTaylor J Bosch, Christopher Groth, Arturo I Espinoza, et al.
British Journal of Cancer|November 11, 2018
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progressionChristopher Groth, Xiaoying Hu, Rebekka Weber, et al.
Cancers|October 23, 2021
Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of NeutrophilsLudovica Arpinati, Naomi Kaisar-Iluz, Merav E Shaul, et al.
Frontiers in Immunology|June 27, 2018
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint InhibitorsRebekka Weber, Viktor Fleming, Xiaoying Hu, et al.
Frontiers in Immunology|March 20, 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced ImmunosuppressionViktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Cellular Immunology|December 9, 2020
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapyRebekka Weber, Christopher Groth, Samantha Lasser, et al.
Pageof 3